Medicare’s 2027 Reset: What the New Part D Rules Mean for Your Clients’ Plans
Good to Know
Most planners treat Medicare as a box the client checks at 65 and a problem for an insurance agent after that. That's a mistake this year. On April 2, CMS finalized its Contract Year 2027 rule for Medicare Advantage and Part D, and the changes land right in the retirement-income plans you've already built.[1] Open Enrollment runs October 15 to December 7 for coverage that starts January 1 — the one window most of your clients have to react.[2]
The headline for planning is Part D. The Inflation Reduction Act capped out-of-pocket drug costs at $2,000 in 2025; that cap is $2,100 in 2026 and rises to $2,400 in 2027, and the old “coverage gap” — the donut hole — is gone.[3] For a client with serious prescription costs, a hard ceiling on drug spending changes their cash-flow math in a way that used to be impossible to promise.
What actually changed
The CY2027 rule finalizes the Part D redesign — eliminating the coverage-gap phase, holding a defined annual out-of-pocket ceiling, and removing cost-sharing once a client reaches the catastrophic level.[1] It also strips out roughly a third of the quality measures behind Medicare Advantage Star Ratings and loosens some marketing rules for agents.[1] The Star Ratings change matters to advisors indirectly: the star score your client leans on to compare plans now measures less than it used to, so “it's a 4-star plan” is a weaker signal than it was a year ago.
An advisor scenario
ADVISOR SCENARIO
A client, 68, retired two years ago on a plan you built around roughly $6,000 a year in prescription costs during her worst years. Under the old rules, a new specialty drug could have pushed her drug spending past $10,000 and quietly wrecked the plan.
Under the 2027 structure, her out-of-pocket drug costs stop at $2,400 — full stop. That doesn't just help her; it lets you model her essential spending with a firmer number and retire the large, vague “drug-cost shock” contingency you'd been carrying.
There is a real caveat here, and it belongs in the conversation: averages describe populations, not the client in front of you. Spending tends to trace a “smile,” drifting down in real terms through the active years and ticking back up late in life, largely for health care. A plan that assumes decline and ignores a possible long-term-care event isn’t sophisticated — it’s naive in a different direction.
What it means for the plan
A firm drug cap replaces an open-ended risk, so rebuild the healthcare line in retirement plans with the capped number — and keep drug costs (now bounded) separate from premiums, IRMAA surcharges, and long-term-care risk (still not). With Star Ratings measuring less, help clients compare plans on their own drugs, pharmacies, and total expected cost rather than the star score alone. And treat the calendar as part of the advice: if a client's plan, formulary, or health changed this year, the October–December window is the review that matters.
A Medicare-season protocol
You can run this without becoming an insurance expert:
1
Flag every client 63 and older now.
Note who's approaching 65, who's in a Medicare Advantage or Part D plan, and who had a health or drug change this year.
2
Send a plain-language nudge before October 15.
Give clients the enrollment window, the new $2,400 drug cap, and the reminder that “same plan as last year” is a decision, not a default.
3
Reframe the healthcare line in the plan.
Use the capped drug number; keep premiums, IRMAA, and long-term care as separate, still-uncapped risks.
4
Coordinate, don't sell.
If a client needs plan-specific advice, connect them with a licensed Medicare specialist — your role is the planning, not the policy.
5
Document the review.
A note that you raised Medicare during Open Enrollment is both good service and good file-keeping.
The Bottom Line
Medicare has always sat awkwardly between “the client's problem” and “the plan's problem.” The 2027 changes move it firmly into the plan: a hard drug-cost ceiling changes the numbers you model, and a thinner Star Rating changes the advice you give. Advisors who treat the fall enrollment window as a planning event, not an insurance errand, protect both the client's budget and the plan's credibility.
For anyone building toward the CFP® marks, this is the kind of cross-domain judgment — tax, cash flow, health coverage, and timing in one conversation — that the certification is designed to develop.
Sources
- CMS. Contract Year 2027 Medicare Advantage and Part D Final Rule (Fact Sheet). April 2, 2026. cms.gov/newsroom/fact-sheets/contract-year-2027-medicare-advantage-part-d-final-rule(opens in new tab)
- Medicare.gov. When can I join, switch, or drop a plan? (Open Enrollment, Oct 15–Dec 7). medicare.gov/basics/get-started-with-medicare(opens in new tab)
- KFF. Changes to Medicare Part D — out-of-pocket cap of $2,100 in 2026, rising to $2,400 in 2027. kff.org/medicare(opens in new tab)
